Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Neoplasms 1Ovarian Neoplasms 1Fallopian Tube Neoplasms 1

Interventions

Paclitaxel 6Radiotherapy 2Pemetrexed 2Carboplatin 2Brachytherapy 2tucatinib 1seribantumab 1osimertinib 1gedatolisib 1fosaprepitant 1fluciclovine F-18 1cobimetinib 1atezolizumab 1alovudine 1Trastuzumab 1Therapeutics 1TP protocol 1Saline Solution 1Radiation 1Protons 1Palliative Care 1Nivolumab 1Letrozole 1Immunoglobulin G 1Imatinib Mesylate 1Ifosfamide 1Gemcitabine 1Fulvestrant 1FANG vaccine 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Uterine Neoplasms × TP protocol × Clear all
NCT00582205 2021-05-19

Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma

University of Oklahoma

Phase 2 Terminated
21 enrolled 7 charts
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡